The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Select Medical Holdings Corp

NYSE: SEM
Last

(U.S.) $17.50

Today's change+0.10 +0.57%
Updated November 24 1:02 PM EST. Delayed by at least 15 minutes.
 

Select Medical Holdings Corp

NYSE: SEM
Last

(U.S.) $17.50

Today's change+0.10 +0.57%
Updated November 24 1:02 PM EST. Delayed by at least 15 minutes.

Select Medical Holdings Corp up (U.S.)$0.10

Select Medical Holdings Corp closed up Friday by (U.S.)$0.10 or 0.57% to (U.S.)$17.50. Over the last five days, shares have gained 2.64% and 32.08% year to date. Shares have outperformed the S&P 500 by 18.68% during the last year.

Key company metrics

  • Open(U.S.) $17.55
  • Previous close(U.S.) $17.40
  • High(U.S.) $17.55
  • Low(U.S.) $17.25
  • Bid / Ask-- / --
  • YTD % change+32.08%
  • Volume105,962
  • Average volume (10-day)567,703
  • Average volume (1-month)1,201,920
  • Average volume (3-month)974,598
  • 52-week range(U.S.) $12.00 to (U.S.) $19.78
  • Beta1.41
  • Trailing P/E23.55×
  • P/E 1 year forward20.47×
  • Forward PEG1.36×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.74
Updated November 24 1:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+2.74%

Based on its net profit margin of 2.74%, Select Medical Holdings Corp is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.21%Sector:HealthcareIndustry:Healthcare Facilities

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue1,0971,1211,1111,046
Total other revenue--------
Total revenue1,0971,1211,1111,046
Gross profit158200183136
Total cost of revenue939920928910
Total operating expense1,0251,0051,039991
Selling / general / administrative47464943
Research & development--------
Depreciation / amortization39384337
Interest expense (income), net operating--------
Unusual expense (income)0--200
Other operating expenses, total--------
Operating income721167256
Interest income (expense), net non-operating-38-38-41-42
Gain (loss) on sale of assets--------
Other--------
Income before tax39843724
Income after tax25512320
Income tax, total1432134
Net income18421620
Total adjustments to net income-1-1-1-1
Net income before extra. items18421620
Minority interest-6-9-80
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items18411520
Inc. avail. to common incl. extra. items18411520
Diluted net income18411520
Dilution adjustment1------
Diluted weighted average shares129129129128
Diluted EPS excluding extraordinary itemsvalue per share0.140.320.120.15
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.140.320.220.15